Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NODE PHARMA AS
AS
Active
Org 927025965
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NODE PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
3M
6M
9M
13M
0M
2021
1M
2022
4M
2023
11M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
-1M
-100%
2022
-1M
0%
2023
0M
+100%
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
263
1 313
3 965
11 215
Staff expenses
−0
−494
−2 736
−5 334
EBITDA
−61
−581
−1 498
−358
Depreciation & amort.
−0
−0
−0
−0
EBIT
−61
−581
−1 498
−358
Net financials
0
−0
4
14
Profit before tax
−61
−582
−1 494
−344
Tax
−0
−0
−0
−0
Net profit
−61
−582
−1 494
−344
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
203
1 130
6 539
8 096
Equity
−27
−609
1 297
2 753
Long-term debt
200
888
878
853
Short-term debt
29
851
4 364
4 491
Total debt
229
1 739
5 242
5 344
Financial ratios
5-year trend
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
2021
2024
Equity ratio
34.0%
This company
38.2%
Market median
+11% vs market
2021
2024
Return on equity
-12.5%
This company
18.4%
Market median
-168% vs market
2021
2024
Net profit margin
-3.1%
This company
8.1%
Market median
-138% vs market
2021
2024
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
2021
2024
Debt / equity
1.94×
This company
0.62×
Market median
-213% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-03-12 – 2021-12-31
View
PDF
More on NODE PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
